LANXESS worldwide

Corporate Website en | de

Asia

EMEA

Americas

Interactive Worldmap

Find all the contact information for the LANXESS sites worldwide

find out more
Contact

2017-08-03

LANXESS Saltidin Brings More Choices for Chinese Consumers to Stay Away From Mosquito

August 3, 2017, Shanghai – Under the scorching sun of summer, all kinds of pests have begun to ravage, bringing people painful, itchy insect bites, and greatly increasing the risk of the spread of infectious diseases along with the global trade, travel, urbanization and climate change. If you want to spend the summer outdoors comfortably, you should have effective protection against the insect bites.

 

According to the information released by World Health Organization (WHO) in 2016, up to one million people are killed each year due to the infectious diseases carried by mosquitoes and other arthropods, taking up 17% of all infectious diseases. In many regions of the world, dangerous diseases, such as malaria, yellow fever and the West Nile virus, are spread by mosquitoes, flies and other insects. Meanwhile, survey data shows that the global issue of the pests’ resistance to pesticides has become increasingly prominent, for which the WHO calls on countries to take action to prevent pests’ resistance to pesticides increases by using new vector control tools such as the insect repellent.

 

In the 1900s, an effective technical material named Saltidin (also known as Icaridin and Picaridin) , it was developed as a new active ingredient for insect repellents and is now produced by Saltigo, a wholly owned subsidiary of the German specialty chemicals company LANXESS It is recommended by the WHO for being safe, reliable and effective. It’s safe enough to be used by the pregnant women, mothers in lactation and children under two years old.

 

Saltidin repels pests by influencing their olfactory receptors. So, they are incapable of recognizing people as the target for blood. As a result, the pests will stay away. Saltidin is colorless and odorless, yet with a smooth feel. It will not stimulate, sensitize or adhere to the skin, while having excellent anti-sweat and lasting anti-mosquito effects. It can be dissolved in a mixture of alcohol and water colorlessly, and it has the features of microbiological stability and is non-corrosiveness. Comprehensive laboratory and field tests demonstrate that it is widely effective for repelling hematophagous insects such as mosquitoes, flies and ticks etc.

 

Because it has no effects to skin sensitization and of its low toxicity, Saltidin has gained worldwide recognition and has been used to make insect repellents by many manufacturers worldwide. Saltidin has been sold in the EU countries since 1990s and occupied a significant market share in Europe. In 2000, it was registered by the US Environmental Protection Agency (EPA) as an insect repellent ingredient, and it began to be sold in the United States. Insect repellents containing the active ingredient Saltidin are marketed in Japan since 2015 upon the approval of the Ministry of Health, Labor and Welfare. On November 5, 2012, Saltidin passed the rigorous comparative test and gained approval by the Chinese government agencies, completing the formal registration.

 

With the higher requirements for efficacy and safety on repellents for personal uses, plus the "Second Child" policy carried out by the Chinese government, the demands for effective and safe repellents in the pregnancy and infancy market are increasing.  The new insect repellent products, including the mosquito repellent liquid, are gradually becoming popular in the terminal sales by appealing to the consumer’s demands of safer and more convenient products, despite that traditional disc mosquito coils still occupy  half of the market. This trend is particularly evident in the first-tier and second-tier markets and in economically developed areas.

 

Since Saltidin has the perfect balance of efficacy, safety and ease, which has been proven to be an ideal insect repellent technical material after careful selections and tests. Some local insect repellent brands have also started using insect repellent technical material Saltidin to bring new choices for Chinese consumers in order to stay away from mosquito threats and enjoy a fresh summer.

 

"Our active ingredient is not a pesticide and is harmless to the humans, so the formulations developed on the base of this active ingredient can be used by the pregnant women and children." said Ruan Qinglin, the head of Saltigo Business Department, LANXESS China, "In addition to its superior efficacy and formulation, safety is also an outstanding feature of Saltidin®, which has never received any complaint about life and health in more than 40 countries over the past 20 years."

 

The World Health Organization (WHO) recommends the insect repellents containing Saltidin as the first choice for preventing diseases such as malaria, dengue fever and Zica fever, etc.; in 2012, Saltidin was identified as a preferred insect repellent for the travelers in the age range from 6 months to 12 years old by Health Canada. According to the survey by Stiftung Warentest (Aprile, 2017), comparing to other active ingredients, Saltidin had won the heart of European consumers by its superior ability in skin resistance.

 

 

About LANXESS

LANXESS is a leading specialty chemicals company with sales of EUR 7.7 billion in 2016 and about 19,200 employees in 25 countries. The company is currently represented at 75 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World) and FTSE4Good.

 

LANXESS China

On Jan. 31, 2005, LANXESS AG was initially listed on the Frankfurt Stock Exchange, and its subsidiary LANXESS Chemical (China) Co., Ltd. officially began operations. Today, LANXESS has 17 subsidiaries including 3 joint ventures, 9 production sites as well as 9 R&D centers with about 1,900 employees in Greater China. LANXESS works closely with its local partners to develop market-oriented solutions that meet local market needs.

 

Forward-Looking Statements

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

 

Information for editors:

All LANXESS news releases and accompanying photo, video and audio materials can be found at http://www.lanxess.cn, http://www.weibo.com/lanxess, or LANXESS’ official WeChat account: LANXESS_china

Contact

Xiao Aoshuang

Xiao Aoshuang
Corporate Communications

LANXESS Chemical (China) Company Limited
Shanghai Office

6F, 5 Corporate Avenue

150 Hu Bin Road, Huangpu District

200021 Shanghai

China, CN

Phone: +86 21 6109 6666

Fax: +86 21 6109 1427

send E-Mail

Yu Fiona

Yu Fiona
Corporate Communications

Phone: +86 21 6109 6666

Fax: +86 21 6109 6717

send E-Mail